Next generation Bifidobacteria probiotics developed using CRISPR gene editing technology are one step closer after a new paper showed how select techniques could be applied in a programmable and strain-dependent manner.
Arcadia Biosciences is a publicly-traded crop innovation company that is pioneering new developments in hemp through plant breeding technology and gene editing.